Table 5.
associated risk factors for TB infection in study participants based on GeneXpert as diagnostic techniques, October 2020 - February 2021
| Variable | Adjusted odd ratio | Std error | Z-value | P-value | 95% CI |
|---|---|---|---|---|---|
| Gender | |||||
| Male | Reference group | ||||
| Female | 0.85 | 0.09 | -1.50 | 0.13 | 0.69 - 1.04 |
| Age group | |||||
| 0 - 19 | Reference group | ||||
| 20 - 39 | 1.27 | 0.26 | 1.16 | 0.24 | 0.85 - 1.89 |
| 40 - 59 | 0.99 | 0.19 | -0.06 | 0.95 | 0.66 - 1.47 |
| ≥ 60 | 0.90 | 0.19 | -20.48 | 0.63 | 0.58 - 1.38 |
| Case definition | |||||
| New | Reference group | ||||
| Relapse | 1.23 | 0.78 | 2.09 | 0.78 | 0.18 - 3.61 |
| Previously treated | 7.69 | 0.00 | -18.95 | 0.00* | 4.76 - 11.11 |
| Others | 41.64 | 0.00 | -10.50 | 0.00* | 25.64 - 66.67 |
| HIV status | |||||
| Positive | 3.69 | 0.68 | 7.07 | 0.00* | 2.57 - 5.29 |
| Negative | Reference group |